Predict your next investment

Corporation
HEALTHCARE | Medical Information
biopharmcommunications.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$62.79M

About BioPharm Communications

BioPharm Communications specializes in providing non-personal, peer-to-peer solutions to the pharmaceutical and biotechnology industries. The company develops promotional medical education programs in collaboration with key opinion leaders and delivers it to healthcare practitioners through its suite of branded programs and multi-channel capabilities, including targeted direct mail, e-mail, web hosting, web banners/display advertising, search engine marketing, DVDs, mobile devices, selling kits, e-meetings and teleconferences.In March 2012, Southfield Capital acquired a majority ownership in BioPharm Communications. Terms of the deal were not released.

BioPharm Communications Headquarter Location

30 W Bridge Street Suite 4

New Hope, Pennsylvania, 18938,

United States

215-862-4902

Latest BioPharm Communications News

Southfield Capital Sells BioPharm Communications to Omnicom Health Group

Jun 9, 2016

11:00 ET from Southfield Capital GREENWICH, Conn., June 9, 2016 /PRNewswire/ -- Southfield Capital, a leading lower middle market private equity firm, announced today that it has completed the sale of BioPharm Communications ("BioPharm") to Omnicom Health Group. BioPharm is a leading communications agency that specializes in proprietary, multichannel marketing programs to physicians and healthcare practitioners for pharmaceutical and biotechnology clients. Southfield Capital acquired BioPharm in 2012 in partnership with the company's two founders, Jeff Persinger and Daniel Egeland. During Southfield's ownership, BioPharm experienced tremendous growth. The company's exceptional performance is primarily attributed to the broadening of its product suite, the expansion and institutionalization of the sales organization and the augmentation of the leadership team. The sale represents a very successful exit for Southfield's investors and the management shareholders. "Southfield was a fantastic partner, not only from a financial perspective but also from a strategic standpoint, and the Southfield team made significant contributions to our growth over the past four years," said Jeff Persinger, President and CEO of BioPharm. Heb James, a Partner with Southfield Capital, commented on the sale, "This outstanding exit is clear validation of the incredible value the talented team at BioPharm has created over the last few years. It's been such a pleasure working with the folks at BioPharm. They should be very proud of their accomplishments, and I wish them the best of luck with Omnicom. "  The acquirer, Omnicom Health Group, is the largest healthcare marketing and communications group in the world. Petsky Prunier acted as the financial advisor to BioPharm. Finn Dixon & Herling acted as legal advisor to BioPharm. About BioPharm Founded in New Hope, PA in 2005, BioPharm Communications ( www.biopharmcommunications.com ) helps brand teams at pharmaceutical and biotech companies execute customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. As part of a customized 360º strategy, BioPharm educates healthcare professionals through the Peer-to-Peer360º suite, differentiates and builds brand awareness through the brand360° campaign approach, and tracks engagement instantly via the Insights360° CRM platform. About Southfield Capital Southfield Capital is a private equity firm that invests in exceptional, growing companies in the lower middle market. The firm makes control investments in North American companies generating $4 - 12 million in EBITDA with proven business models, attractive growth and profitability trends, and strong leadership. For more information, please visit  www.southfieldcapital.com . To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/southfield-capital-sells-biopharm-communications-to-omnicom-health-group-300281698.html SOURCE Southfield Capital

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.